FIELD: chemico-pharmaceutical industry.
SUBSTANCE: the present innovation deals with applying the compound of formula I
for treating neuropathic pains. This compound I (retigabin) is of high efficiency in treating allodynia, hyperalgesia-conditioned pains, neuropathic pain in case of diabetic neuropathy, neuropathic pain at migraine. The compound suggested is low toxic being of high bioavailability.
EFFECT: higher efficiency of therapy.
6 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| (S)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695647C2 |
| (R)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695607C2 |
| NEW PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN | 2008 |
|
RU2462459C2 |
| METHODS OF THERAPEUTIC APPLICATION OF STEROID COMPOUNDS | 2006 |
|
RU2427375C2 |
| COMBINATIONS OF PALMITOYLETHANOLAMIDE FOR TREATING CHRONIC PAIN | 2018 |
|
RU2701720C1 |
| METHOD OF TREATING NEUROPATHIC PAIN AND ASSOCIATED WITH IT SYNDROMES | 2005 |
|
RU2433825C2 |
| METHOD FOR PREVENTING PHANTOM PAIN SYNDROME FOLLOWING AMPUTATION OF EXTREMITY | 2011 |
|
RU2446795C1 |
| METHOD OF TREATING PAIN AFTER LIMB AMPUTATION | 2023 |
|
RU2823155C1 |
| METHOD FOR DETERMINING INDICATIONS FOR GABAPENTIN TREATMENT OF PAIN SYNDROME IN BURNING EYE SYNDROME | 2022 |
|
RU2786958C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING GABAPENTIN OR ITS ANALOG AND α-AMINOAMIDE AND ITS USING AS ANALGESIC | 2002 |
|
RU2295337C2 |
